Dr Runlin Gao (Fu Wai Hospital, Beijing, China) discusses the prospective randomized trial of the NOYA sirolimus-eluting stent with a biodegradable coating compared with the Firebird 2 sirolimus-eluting stent with a durable coating in patients with coronary artery disease: Nine-month angiographic and 12-month clinical results. Filmed in Paris during EuroPCR 2011 on May 18.